Merck Purchases Rights to Ebola Vaccine

Drug Industry Daily
A A
Merck has gained exclusive licensing rights to an experimental Ebola vaccine that is still undergoing clinical trials under a deal with NewLink Genetics.

To View This Article:

Login

Subscribe To Drug Industry Daily